Suicide − a serious health and social problem with the possibility of prevention

1. WHO. Preventing suicide: a community engagement toolkit. Pilot version 1.0. World Health Organization, 2014. Dostupné na: www.who.int/mental_health/suicide-prevention/en/

2. Ahmedani BK, Simon GE, Stewart C et al. Health care contacts in the year before suicide death. J Gen Intern Med 2014; 29: 870–877.

3. Nock MK, Green JG, Hwang I et al. Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement. JAMA Psychiatry 2013; 70: 300–310.

4. Borges G, Nock MK, Haro Abad JM et al. Twelve-month prevalence of and risk factors for suicide attempts in the World Health Organization World Mental Health Surveys. J Clin Psychiatry 2010; 71: 1617–1628.

5. Nock MK, Borges G, Bromet EJ et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry 2008; 192: 98–105.

6. Weissman MM, Bland RC, Canino GJ et al. Prevalence of suicide ideation and suicide attempts in nine countries. Psychol Med 1999; 29: 9–17.

7. Johnston AK, Pirkis JE, Burgess PM. Suicidal thoughts and behaviours among Australian adults: findings from the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2009; 43: 635–643.

8. Jeon HJ, Lee JY, Lee YM et al. Lifetime prevalence and correlates of suicidal ideation, plan, and single and multiple attempts in a Korean nationwide study. J Nerv Ment Dis 2010; 198: 643–646.

9. Carroll R, Metcalfe C, Gunnell D. Hospital presenting self-harm and risk of fatal and non-fatal repetition: systematic review and meta-analysis. PLoS One 2014; 9: e89944.

10. Brezo J, Paris J, Barker ED et al. Natural history of suicidal behaviors in a population-based sample of young adults. Psychol Med 2007; 37: 1563–1574.

11. Patton GC, Coffey C, Sawyer SM et al. Global patterns of mortality in young people: a systematic analysis of population health data. Lancet 2009; 374: 881–892.

12. Conwell Y, Van Orden K, Caine ED. Suicide in older adults. Psychiatr Clin North Am 2011; 34: 451–468.

13. Christodoulou C, Douzenis A, Papadopoulos FC et al. Suicide and seasonality. Acta Psychiatr Scand 2012; 125: 127–146.

14. Arltová M, Antovová M. Statistická analýza sebevražednosti v České republice z pohledu časových řad. Demografie 2016; 58: 29–48.

15. King M, Smith A, Gracey M. Indigenous health part 2: the underlying causes of the health gap. Lancet 2009; 374: 76–85.

16. Egeland JA, Sussex JN. Suicide and family loading for affective disorders. JAMA 1985; 254: 915–918.

17. Jollant F, Malafosse A, Docto R, Macdonald C. A pocket of very high suicide rates in a non-violent, egalitarian and cooperative population of South-East Asia. Psychol Med 2014; 17: 1–7.

18. Fountoulakis KN, Kawohl W, Theodorakis PN et al. Relationship of suicide rates to economic variables in Europe: 2000–2011. Br J Psychiatry 2014; 205: 486–496.

19. Reeves A, McKee M, Stuckler D. Economic suicides in the great recession in Europe and North America. Br J Psychiatry 2014; 205: 246–247.

20. Pirkis J, Nordentoft M. Media influences on suicide and attempted suicide. In: O’Connor RC, Platt S, Gordon J (eds.). International handbook of suicide prevention: research, policy and practice. John Wiley & Sons, Chichester, Malden, 2011: 531–544.

21. Brent DA, Bridge J, Johnson BA, Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry 1996; 53: 1145–1152.

22. Kim CD, Seguin M, Therrien N et al. Familial aggregation of suicidal behavior: a family study of male suicide completers from the general population. Am J Psychiatry 2005; 162: 1017–1019.

23. Tidemalm D, Runeson B, Waern M et al. Familial clustering of suicide risk: a total population study of 11.4 million individuals. Psychol Med 2011; 41: 2527–2534.

24. Brent DA, Melhem N. Familial transmission of suicidal behavior. Psychiatr Clin North Am 2008; 31: 157–177.

25. Schulsinger F, Kety SS, Rosenthal D, Wender PH. A family study of suicide. In: Schou M, Strömgren E (eds.). Origin, Prevention and Treatment of Affective Disorders. Academic Press, London, 1979: 277–287.

26. Statham DJ, Heath AC, Madden PA et al. Suicidal behaviour: an epidemiological and genetic study. Psychol Med 1998; 28: 839–855.

27. Fu Q, Heath AC, Bucholz KK et al. A twin study of genetic and environmental influences on suicidality in men. Psychol Med 2002; 32: 11–24.

28. Lieb R, Bronisch T, Höfler M et al. Maternal suicidality and risk of suicidality in offspring: findings from a community study. Am J Psychiatry 2005; 162: 1665–1671.

29. Turecki G. The molecular bases of the suicidal brain. Nat Rev Neurosci 2014; 15: 802–816.

30. O’Connor RC, Nock MK. The psychology of suicidal behaviour. Lancet Psychiatry 2014; 1: 73–85.

31. Haas AP, Eliason M, Mays VM et al. Suicide and suicide risk in lesbian, gay, bisexual, and transgender populations: review and recommendations. J Homosex 2011; 58: 10–51.

32. Fergusson DM, Woodward LJ, Horwood LJ. Risk factors and life processes associated with the onset of suicidal behaviour during adolescence and early adulthood. Psychol Med 2000; 30: 23–39.

33. Brezo J, Paris J, Vitaro F et al. Predicting suicide attempts in young adults with histories of childhood abuse. Br J Psychiatry 2008; 193: 134–139.

34. Heim C, Shugart M, Craighead WE, Nemeroff CB. Neurobiological and psychiatric consequences of child abuse and neglect. Dev Psychobiol 2010; 52: 671–690.

35. McGowan PO, Sasaki A, D’Alessio AC et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009; 12: 342–348.

36. Turecki G, Meaney MJ. Effects of the social environment and stress on glucocorticoid receptor gene methylation: a systematic review. Biol Psychiatry 2016; 79: 87–96.

37. Weder N, Zhang H, Jensen K et al. Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitry. J Am Acad Child Adolesc Psychiatry 2014; 53: 417–424.

38. Labonté B, Suderman M, Maussion G et al. Genome-wide epigenetic regulation by early-life trauma. Arch Gen Psychiatry 2012; 69: 722–731.

39. Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 2009; 65: 760–769.

40. Ernst C, Deleva V, Deng X et al. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch Gen Psychiatry 2009; 66: 22–32.

41. Keller S, Sarchiapone M, Zarrilli F et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry 2010; 67: 258–267.

42. Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry 2012; 69: 1123–1130.

43. Arling TA, Yolken RH, Lapidus M et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 2009; 197: 905–908.

44. Flegr J. How and why Toxoplasma makes us crazy. Trends Parasitol 2013; 29: 156–163.

45. McGirr A, Renaud J, Bureau A et al. Impulsive-aggressive behaviours and completed suicide across the life cycle: a predisposition for younger age of suicide. Psychol Med 2008; 38: 407–417.

46. Séguin M, Beauchamp G, Robert M et al. Developmental model of suicide trajectories. Br J Psychiatry 2014; 205: 120–126.

47. Yang B, Clum GA. Childhood stress leads to later suicidality via its effect on cognitive functioning. Suicide Life Threat Behav 2000; 30: 183–198.

48. Sinclair JM, Crane C, Hawton K, Williams JM. The role of autobiographical memory specificity in deliberate self-harm: correlates and consequences. J Affect Disord 2007; 102: 11–18.

49. Lee FS, Heimer H, Giedd JN et al. Mental health. Adolescent mental health − opportunity and obligation. Science 2014; 346: 547–549.

50. van den Bos R, Harteveld M, Stoop H. Stress and decision-making in humans: performance is related to cortisol reactivity, albeit differently in men and women. Psychoneuroendocrinology 2009; 34: 1449–1158.

51. Williams JM, Barnhofer T, Crane C, Beck AT. Problem solving deteriorates following mood challenge in formerly depressed patients with a history of suicidal ideation. J Abnorm Psychol 2005; 114: 421–431.

52. McGirr A, Diaconu G, Berlim MT et al. Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicide. J Psychiatry Neurosci 2010; 35: 399–408.

53. Grover KE, Green KL, Pettit JW et al. Problem solving moderates the effects of life event stress and chronic stress on suicidal behaviors in adolescence. J Clin Psychol 2009; 65: 1281–1290.

54. Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry 2004; 4: 37.

55. Hoertel N, Franco S, Wall MM et al. Mental disorders and risk of suicide attempt: a national prospective study. Mol Psychiatry 2015; 20: 718–726.

56. Holma KM, Haukka J, Suominen K et al. Differences in incidence of suicide attempts between bipolar I and II disorders and major depressive disorder. Bipolar Disord 2014; 16: 652–661.

57. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002; 68: 167–181.

58. Sharifi V, Eaton WW, Wu LT et al. Psychotic experiences and risk of death in the general population: 24−27 year follow-up of the Epidemiologic Catchment Area study. Br J Psychiatry 2015; 207: 30–36.

59. Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol 2010; 24: 81–90.

60. Nock MK, Hwang I, Sampson NA, Kessler RC. Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication. Mol Psychiatry 2010; 15: 868–876.

61. Tyrer P, Reed GM, Crawford MJ. Classification, assessment, prevalence, and effect of personality disorder. Lancet 2015; 385: 717–726.

62. Ernst C, Lalovic A, Lesage A et al. Suicide and no axis I psychopathology. BMC Psychiatry 2004; 4: 7.

63. Conner KR, Beautrais AL, Brent DA et al. The next generation of psychological autopsy studies. Part I. Interview content. Suicide Life Threat Behav 2011; 41: 594–613.

64. Kim C, Lesage A, Seguin M et al. Patterns of co-morbidity in male suicide completers. Psychol Med 2003; 33: 1299–1309.

65. Akechi T, Iwasaki M, Uchitomi Y, Tsugane S. Alcohol consumption and suicide among middle-aged men in Japan. Br J Psychiatry 2006; 188: 231–236.

66. Park JE, Lee JY, Jeon HJ et al. Age-related differences in the influence of major mental disorders on suicidality: a Korean nationwide community sample. J Affect Disord 2014; 162: 96–101.

67. Conwell Y, Duberstein PR, Cox C et al. Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry 1996; 153: 1001–1008.

68. Phillips MR, Yang G, Zhang Y et al. Risk factors for suicide in China: a national case-control psychological autopsy study. Lancet 2002; 360: 1728–1736.

69. Rajkumar R, Fam J, Yeo EY, Dawe GS. Ketamine and suicidal ideation in depression: jumping the gun? Pharmacol Res 2015; 99: 23–35.

70. Black C, Miller BJ. Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients. Biol Psychiatry 2015; 78: 28–37.

71. Turecki G. Polyamines and suicide risk. Mol Psychiatry 2013; 18: 1242–1243.

72. Nemeroff CB, Owens MJ, Bissette G et al. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 1988; 45: 577–579.

73. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 2000; 48: 766–777.

74. Bernard R, Kerman IA, Thompson RC et al. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry 2011; 16: 634–646.

75. Ernst C, Nagy C, Kim S et al. Dysfunction of astrocyte connexins 30 and 43 in dorsal lateral prefrontal cortex of suicide completers. Biol Psychiatry 2011; 70: 312–319.

76. Asberg M, Thorén P, Träskman L et al. “Serotonin depression”—a biochemical subgroup within the affective disorders? Science 1976; 191: 478–480.

77. Arango V, Underwood MD, Mann JJ. Serotonin brain circuits involved in major depression and suicide. Prog Brain Res 2002; 136: 443–453.

78. Sullivan GM, Oquendo MA, Milak M et al. Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder. JAMA Psychiatry 2015; 72: 169–178.

79. Brezo J, Bureau A, Mérette C et al. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study. Mol Psychiatry 2010; 15: 831–843.

80. Sequeira A, Mamdani F, Ernst C et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009; 4: e6585.

81. Choudary PV, Molnar M, Evans SJ et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005; 102: 15653–15658.

82. Rajkumar R, Fam J, Yeo EY, Dawe GS. Ketamine and suicidal ideation in depression: jumping the gun? Pharmacol Res 2015; 99: 23–35.

83. Wenzel A, Brown GK, Beck AT. Classification and assessment of suicide ideation and suicidal acts. In: Wenzel A, Brown GK, Beck AT (eds.). Cognitive therapy for suicidal patients: Scientific and clinical applications. American Psychological Association, Washington, DC, 2009, s. 377.

84. Moller-Leimkuhler AM. Barriers to help seeking by men: A review of sociocultural and clinical literature with particular reference to depression. J Affect Disord 2002; 71: 1–9.

85. McKelvey RS, Pfaff JJ, Acres JG. The relationship between chief complaints, psychological distress, and suicidal ideation in 15–24 year-old patients presenting to general practitioners. Med J Aust 2001; 175: 550–552.

86. Busch KA, Fawcett J, Jacobs DJ. Clinical correlates of inpatient suicide. J Psychiatry 2003; 64: 14–19.

87. Louma JB, Martin CE, Pearson JL. Contact with mental health and primary care providers before suicide: A review of the evidence. Am J Psychiatry 2002; 159: 909–916.

88. Feldman MD, Duberstein PR, Vannoy S et al. Let’s not talk about it: Suicide inquiry in primary care. Ann Fam Med 2007; 5: 412–418.

89. Saunders K, Brand F, Lascelles K, Hawton K. The sad truth about the SADPERSONS Scale: An evaluation of its clinical utility in self-harm patients. Emerg Med J 2013; 31: 796–798.

90. Harris KM, Syu JJ, Lello OD et al. The ABC’s of suicide risk assessments: Applying a tripartite approach to individual encounters. PLoS One 2015; 10: e0127442.

91. Bajaj P, Borreani E, Ghosh P et al. Screening for suicidal thoughts in primary care: The views of patients and general practitioners. Mental Health Fam Med 2008; 5: 229–235.

92. Vail L, Adams A, Gilbert E et al. Investigating mental health risk assessment in primary care and the potential role of a structured decision support tool, GRIST. Ment Health Fami Medi 2012; 9: 57–67.

93. Mott JA. An integrated approach to estimating suicide risk. Suicide Life Threat Behav 1991; 21: 74–89.

94. Chan WI, Batterham P, Christensen H, Galletly C. Suicide literacy, suicide stigma, and help-seeking intentions in Australian medical students. Australas Psychiatry 2014; 22: 132–139.

95. Graham RD, Rudd D, Bryan CJ. Primary care providers’ views regarding assessing and treating suicidal patients. Suicide Life Threat Behav 2011; 41: 614–623.

96. Gunnell D, Bennewith O, Peters TJ et al. Do patients who self-harm consult their general practitioner soon after hospital discharge? A cohort study. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 599–602.

97. Marquet RL, Bartelds AI, Kerkhof AJ et al. The epidemiology of suicide and attempted suicide in Dutch general practice 1983–2003. BMC Fam Pract 2005; 6: 45.

98. Poma SZ, Grossi A, Toniolo E et al. Self-perceived difficulties with suicidal patients in a sample of Italian general practitioners. J Clin Med Res 2011; 3: 303–308.

99. Olfson M, Weissman MM, Leon AC et al. Suicidal ideation in primary care. J Gen Intern Med 1996; 11: 447–453.

100. Riihimaki K, Vuorilehto M, Melartin T et al. Incidence and predictors of suicide attempts among primary-care patients with depressive disorders: a 5-year prospective study. Psychol Med 2014; 44: 291–302.

101. Houston K, Haw C, Townsend E, Hawton K. General practitioner contacts with patients before and after deliberate selfharm. Br J Gen Pract 2003; 53: 365–370.

102. Raue PJ, Brown EL, Meyers BS et al. Does every allusion to possible suicide require the same response? J Fam Pract 2006; 55: 605–612.

103. Fanello S, Paul P, Delbos V et al. General practitioners’ practices and attitudes in regard to suicidal behavior. Santé Publique 2002; 14: 263–273.

104. Verger P, Brabis PA, Kovess V et al. Determinants of early identification of suicidal ideation in patients treated with antidepressants or anxiolytics in general practice: a multilevel analysis. J Affect Disord 2007; 99: 253–257.

105. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 2009; 374: 609–619.

106. Kroenke K, Spitzer RL, Williams JB et al. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994; 3: 774–779.

107. Benca R, Peterson M. Insomnia and depression. Sleep Medicine 2008; 9(Suppl. 1): S3–S9.

108. Perlis ML, Giles DE, Buysse DJ et al. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 1997; 42: 209–212.

109. National Institute for Health and Care Excellence. NICE clinical guideline 90 Depression: The treatment and management of depression in adults. 2009.

110. Arroll B, Khin N, Kerse N. Screening for depression in primary care with two verbally asked questions: cross sectional study. BMJ 2003; 327:1144–1146.

111. U.S. Preventive Services Task Force. Screening for depression: recommendations and rationale. Ann Intern Med 2002; 136(10): 760–764.

112. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003; 41: 1284–1292.

113. Williams JW Jr, Noel PH, Cordes JA et al. Is this patient clinically depressed? JAMA 2002; 287: 1160–1170.

114. Rush AJ, Trivedi MH, Ibrahim HM et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573–583.

115. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess 1996; 67: 588–597.

116. Van Marwijk HW, Wallace P, de Bock GH et al. Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale. Br J Gen Pract 1995; 45: 195–199.

117. Zung WW. Factors influencing the self-rating depression scale. Arch Gen Psychiatry 1967; 16: 543–547.

118. Mueller TI, Leon AC, Keller MB et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999; 156: 1000–1006.

119. Caspi A, Sugden K, Moffitt TE et al. Influence of life stress on expression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386–389.

120. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007; 29: 147–155.

121. Ladin K, Daniels N, Kawachi I. Exploring the relationship between absolute and relative position and late-life depression: evidence from 10 European countries. Gerontologist 2010; 50: 48–59.

122. Lorant V, Croux C, Weich S et al. Depression and socio-economic risk factors: 7-year longitudinal population study. Br J Psychiatry 2007; 190: 293–298.

123. Meltzer H, Bebbington P, Brugha T et al. Job insecurity, socio-economic circumstances and depression. Psychol Med 2010; 40: 1401–1407.

124. Freeman EW, Sammel MD, Lin H et al. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006; 63: 375–382.

125. Desjardins I, Cats-Baril W, Maruti S et al. Suicide risk assessment in hospitals: an expert system-based triage tool. J Clin Psychiatry 2016; 77: e874–882.

126. Swedish Council on Health Technology Assessment. Instruments for suicide risk assessment. SBU, Stockholm, 2015.

127. Suicide risk assessment and the Columbia-Suicide Severity Rating Scale (C-SSRS). Dostupné na: www.youtube.com/watch?v=Xfddz_Yfnc4

128. WHO. Preventing suicide. A global imperative. World Health Organization, 2014.

129. WHO. Preventing suicide. A resource for general physicians. Mental and behavioural disorders. World Health Organization, Geneva, 2000.